|
About
|
Medical oncology. Special training: breast cancer
International scientific associations:
- ESMO – European Society of Medical Oncology.
- ASCO – American Society of Medical Oncology.
- EORTC – European Organization for Research and Treatment of Cancer. Over
200 publications in journals, such as: the Lancet, the New England Journal of Medicine, the Annals of Oncology, the Journal of Clinical Oncology, and the Oncologist.
Title, journal, year of publication: Cortes J, Calvo E, Vivancos A, Perez-Garcia J, Recio JA, Seoane. J. New Approach to Cancer Therapy Based on a Molecularly Defined Cancer Classification. CA Cancer J Clin. 2014
Jan;64(1):70-4 F.I.: 162,500. Swain SM, Baselga J, Kim SB, Ro J, Semiglazov V, Campone M, Ciruelos E, Ferrero JM, Scheneeweiss A, Heeson S, Clark E, Ross G, Benyunes MC, Cortes J. Pertuzumab, Trastuzumab, Docetaxel
in HER2-Positive Metastatic Breast Cancer. New Eng J Med 2015 Feb 19;372(8):724-34
F.I.: 59,558.
Dr. Cortés participated in the following clinical trials that led to the development of targeted therapies in breast cancer: pertuzumab, everolimus, eribuline, evacizumab, abemaciclib, buparlisib, lapatinib, nintedanib. |